Objective. To assess the clinical significance associated with the ide
ntification of fungal elements consistent with Aspergillus in cytology
specimens. Materials and Methods. For all cytology specimens with rep
orted fungal elements consistent with Aspergillus, reported over a 9 y
r and 8 mo period at The Cleveland Clinic Foundation, the patient's me
dical charts were reviewed with particular attention to underlying dis
ease, presentation treatment, and clinical course. Cytology results we
re compared with available microbiologic cultures and tissue specimens
in all of the patients. Results. Forty-five cytology specimens with A
spergillus fungal from 36 patients, were identified Twenty-six patient
s had concurrent specimens sent for culture in whom 11 grew Aspergillu
s species (10 Aspergillus fumigatus), eight grew organisms other than
Aspergillus, and seven were no growth. A total of 16 patients (44%) we
re treated with antifungal treatment (Amphotericin B). Treatment with
Amphotericin B was significantly associated with a concurrent growth o
f Aspergillus species (9/11 patients with Aspergillus culture positive
vs. 7/25 patients without a positive culture for Aspergillus, P value
= 0.004 (ODDS ratio = 11, 95% confidence interval: #1.6 - 104, 2-tail
ed Fisher exact test.) Conclusions. The presence of fungal forms consi
stent with Aspergillus in cytology specimens is neither specific nor s
ensitive for significant infection due to Aspergillus. Treatment with
Amphotericin B is more likely To be instituted when a concurrent clini
cal specimen grows Aspergillus species in culture. (C) 1997 Wiley-Liss
, Inc.